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[Abstract] The Infinium Human Methylation 450 BeadChip technology allows the rapid 
quantitative DNA methylation analysis of more than 485,000 CpG dinucleotides located across 
the genome. The method utilizes sodium bisulfite treatment of genomic DNA to convert 
unmethylated cytosine residues into uracils whereas methylated cytosines remain unchanged. 
Modified DNA is then whole genome amplified, fragmented and hybridized to locus-specific 
oligomer probes linked to individual beads on a BeadChip. Hybridization is followed by single-
base extension of the oligomer with a labeled nucleotide. The BeadChip is subsequently 
fluorescently stained and scanned to measure the intensities of the beads corresponding to the 
unmethylated and methylated CpG sites. 
 
Materials and Reagents 
 
1. EZ-96 DNA Methylation Kit (Zymo Research, catalog number: D5003) 
2. Ethanol (VWR International, catalog number: 20821.330)  
3. Genomic DNA 
4. PCR Grade water (Life Technologies, Invitrogen™, catalog number: AM9937) 
5. PCR reagents: PCR buffer, dNTPs, Taq (Roche Applied Science, catalog number: 
04738420001) 
6. Primers for methylation specific PCR [see Step 20-(1)] 
7. 96-well 0.2 ml microplates (Starlab, catalog number: I1402-9800-C) 
8. 96-well 0.8 ml microplates (Thermo Fisher Scientific, catalog number: AB-0765) 
9. Seal sheets  (Thermo Fisher Scientific, catalog number: AB-0558) 
10. Infinium Human Methylation450 BeadChip Kit (Illumina, catalog number: WG-314-1003) 
11. PyroMark Q96 CpG LINE-1 Kit (QIAGEN, catalog number: 973043) and associated 
reagents (Optional) 
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Equipment 
 
1. 96-well Thermal Cycler  
2. Centrifuge with microplate adapters 
3. Vortex mixer 
4. HiScan SQ or iScan systems (Illumina, catalog number: SY-103-2001 or SY-101-1001 
respectively) 
5. GenomeStudio Methylation Module software (Illumina, catalog number: SW-300-1001)  
6. NanoDrop ND-1000 UV-Vis spectrophotometer (Thermo Fisher Scientific) or equivalent 
7. Speed Vacuum (Optional) 
8. PyroMark Q96 MD (QIAGEN, catalog number: 9001526) or equivalent (Optional) 
 
Procedure 
 
1. Quantitate genomic DNA concentration using NanoDrop and determine A260/280 ratio 
which should be  > 1.80 for samples to be analyzed.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
2. Dilute each DNA sample in water to 100 ng/µl concentration.  
Note: It is also possible to use samples at lower concentrations and adjust the volumes in 
step 6 accordingly to meet the minimum quantity of DNA required. However, volumes of 
DNA samples with lower concentrations used in step 6 should not exceed a maximum 
volume of 45 µl.   
Note: Once DNA is bisulfite treated it should be used for Infinium Methylation analyses as 
soon as possible, preferably within one month. 
3. Prepare Conversion Reagent from EZ96 DNA Methylation Kit by adding 7.5 ml water and 
2.1 ml of M-Dilution buffer to a bottle of CT Conversion Reagent. Mix at room 
temperature with frequent vortexing for 10 min and keep reagent in dark. 
Note: It is normal to see trace amounts of undissolved CT Conversion Reagent. Also, for 
best results the reagent should be immediately used after preparation. 
4. Prepare M-Wash Buffer from EZ96 DNA Methylation Kit by adding 144 ml 100% ethanol 
to the 36 ml M-Wash Buffer concentrate. 
5. Pipet 10 µl of each DNA sample (100 ng/µl) into a 96-well 0.2 ml microplate for bisulfite 
treatment (500 ng is the minimum quantity of DNA used).  
6. Add 5 µl of M-Dilution buffer to each sample and adjust the total volume to 50 µl with 
water and mix by pipetting up and down. Seal with seal sheet.  
7. Incubate samples at 37 °C for 15 min using thermal cycler. 
8. Add 100 µl of the prepared CT Conversion Reagent to each sample and mix by pipetting 
up and down several times. Seal plate with a seal sheet. 
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Note: CT-Conversion Reagent contains 97% Sodium Metabisulfite (bisulfite ions) which 
mediates bisulfite-mediated deamination of unmethylated Cytosine. 
9. Incubate samples on thermal cycler using the following program 
a. 95 °C for 30 sec.  
b. 50 °C for 1 h and repeat steps a and b for 15 more cycles. 
c. 4 °C for 10 min. 
10. From EZ96 DNA Methylation Kit, place Silicon-A Binding Plate on top of Collection Plate 
and pipette 400 µl of M-Binding Buffer to each well. This buffer contains guanidine 
hydrochloride salt which provides pH that enables DNA to bind to the silica particles and 
allows washing and bisulfite treatment of the DNA.  
11. Load the DNA samples from step 10 into the wells of the Silicon-A Binding Plate and mix 
by pipetting up and down. 
12. Centrifuge at room temperature at ≥ 3,000 x g for 5 min and discard the flow-through. 
Use this condition for all centrifugation steps in this protocol. 
13. Add 500 µl of M-wash buffer to each well and centrifuge at ≥ 3,000 x g for 5 min. Discard 
the flow-through. M-wash buffer is to wash and clean any reagent from silica-bound DNA 
from previous step.  
14. Add 200 µl of M-Desulphonation buffer to each well and let it stand at room temperature 
for 15-20 min. After incubation centrifuge at ≥ 3,000 x g for 5 min. Discard the flow-
through. M-Desulphonation buffer contains sodium hydroxide which converts deaminated 
cytosines to Uracil.  
15. Add 500 µl of M-wash buffer to each well and centrifuge at ≥ 3,000 x g for 5 min. Discard 
the flow-through. 
16. Add another 500 µl of M-wash buffer to each well and centrifuge at ≥ 3,000 x g for 10 
min. Ensure there is no liquid left in the wells of Silicon-A binding plate, otherwise 
centrifuge for further 2 min. 
17. Place Silicon A binding plate onto an elution plate.  
18. Add 30 μl of M-Elution Buffer directly to the binding matrix in each well of Silicon A 
Binding Plate. Incubate for 1-2 min at room temperature and centrifuge for 3 min at ≥ 
3,000 x g to elute the DNA. M-elution buffer contains 1% Tris (hydroxymethyl) 
aminomethane/Hydrochloric Acid and 1% Ethylenediaminetetraacetic Acid, pH 8.0 which 
enables dissociation of DNA from silica column.  
19. Keep aside 4 µl of each (bisulfite converted) DNA sample for quality control and store 
remaining amount in the elution plate at -20 °C. 
Note: It is recommended to use bisulfite converted samples on the Infinium 
HumanMethylation450 BeadChip within 1 month of conversion and to avoid repeated 
freeze-thaw cycles of samples. 
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20. Assess the quality of bisulfite converted DNA by using for instance methylation-specific 
PCR (Ku et al., 2011) for gene of interest (see Note below for an example of our 
Methylation-specific PCR for Calponin gene) or using pyrosequencing of LINE1 with 
PyroMark Q96 CpG LINE-1 kit. Proceed with DNA samples which have passed quality 
control, i.e. samples which either show a PCR product with methylation specific PCR or 
have passed the bisulfite modification control contained within the LINE1 pyrosequencing 
assay.  
Notes:  
a. Methylation-specific PCR for Calponin gene for assessing quality of bisulfite treated 
DNA: 
Mix 15.8 µl water with 
2.5 µl 10x PCR buffer  
3 µl MgCl2 (25 mM) 
0.5 µl dNTPs (2.5 mM) 
1 µl Forward Primer (5′-GGAAGGTAGTTGAGGTTGTG-3′, 20 µM) 
1 µl Reverse Primer (5′-CCCAAACTCAAAACTCTAACCTAAC-3′, 20 µM) 
1 µl Bisulfite converted DNA 
0.2 µl Taq (5 U)  
b. PCR conditions:  
95 °C for 6 min  
95 °C for 30 sec  
63 °C for 30 sec  
72 °C for 30 sec  
Repeat steps b to d for 35 cycles 
72 °C for 5 min 
Run PCR products on a 2% agarose gel to confirm presence of amplicons (333 bp) 
which verify that the bisulfite conversion has been successful in respective samples. 
(Teodoridis et al., 2005) 
21. Determine concentration of bisulfite treated DNA using NanoDrop.  
Note: As the bisulfite treatment can degrade DNA samples, we have additional DNA 
quantitation step here after the bisulfite treatment in our protocol, to ensure that there is 
sufficient sample present before proceeding to Infinium Methylation analyses. 
22. Thaw DNA samples stored at -20 °C and briefly centrifuge. Adjust DNA concentration of 
each sample to 50 ng/µl with M-elution buffer or water.  
Note: DNA samples below 50 ng/µl may be concentrated using speed vacuum. 
23. Transfer 6 µl of each 50 ng/µl sample to a new 0.8 ml 96-well microplate which is labeled 
as BCD plate in the Infinium HD Assay Methylation Protocol. 
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24. Process 4 µl (or equivalent of 200 ng) samples according to Infinium HD Assay 
Methylation Protocol Guide (see Reference 3), starting from step 3, page 43 (under steps 
to make MSA4 plate). Briefly, bisulfite converted DNA is whole genome amplified, 
fragmented and hybridized to the BeadChip. Following hybridization, unhybridized DNA is 
washed off and probes on the BeadChip are extended using a labeled nucleotide and 
captured DNA as a template. The BeadChip is fluorescently stained, scanned and the 
intensities of beads are measured.  
25. Following processing, extract DNA methylation signals from scanned arrays.  
26. Background correct raw signals and compute into β value using the GenomeStudio 
software. 
27. Before proceeding to data analysis, perform quality control using the GenomeStudio 
Software. Data quality can be assessed by checking the detection p-value of probes as 
well as the sample-dependent and sample-independent control probes which are present 
on the BeadChips. The following criteria are applied for removal of poorly performing 
probes or samples: a) probes with a detection p-value above a certain cut-off (e.g. p < 
0.05) should be excluded from the analysis, b) samples which fail in any of the array 
control probes i.e. the raw signal intensities of the control probes of the sample are out of 
normal range (median+3SD or median-3SD depending on the control probe type) of the 
signal intensities across all the samples and c) if a certain probe has failed quality control 
via the detection p-value in greater than 10-25% of samples, then that probe should be 
removed from further downstream analyses.  
28. An appropriate method of within and between array normalization should be performed.  
For instance the Genome studio software provides an internal control normalization 
procedure.  
29. The Infinium 450 K BeadChips use two different types of assay chemistries (Infinium I 
and Infinium II probes). The β value represents either the ratio of the intensity of the 
methylated bead type to the combined locus intensity (Infinium type 1 probes) or the ratio 
of the intensity of the signal from the green channel (corresponding to the methylated 
CpG state) to the combined intensity obtained from red and green channels (Infinium 
type II probes) and reflects the methylation status of the specific CpG site. Due to the 
divergent chemistries of Infinium I and II probes which result in different β value 
distributions it is recommended to perform peak base correction or the scaling of probes 
to more accurately reflect the divergent distributions of type I and II probes. Different 
peak base correction methods are publicly available; see for instance in (Teschendorff et 
al., 2013).  
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